Use of the investigational therapy Nirogacestat Reduces Pain in Patients with Desmoid Tumors
Use of nirogacestat showed sustained reduction of pain for patients with progressing desmoid tumors when compared with placebo, according to data from 3 patient-completed pain assessment tools in the phase 3 DeFi trial (NCT03785964).1 Findings with the with the investigational gamma secretase inhibitor presented at the2023 ASCO Annual Meeting showed that patients who received nirogacestat … [Read more…]